Johnson & Johnson News Headlines

JNJ 
$98.96
*  
0.21
 negative 
0.21%
Get JNJ Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Watson Ups Generic Count - Analyst Blog
3/13/2012 9:21:11 AM - Zacks.com

New Surgical Devices from Covidien - Analyst Blog
3/12/2012 3:21:37 PM - Zacks.com

Cooper Surpasses, Profit Up - Analyst Blog
3/12/2012 9:21:33 AM - Zacks.com

Shire Initiates Trials for Vyvanse - Analyst Blog
3/9/2012 6:20:01 PM - Zacks.com

Covidien Intros HALO60 Catheter - Analyst Blog
3/8/2012 3:23:01 PM - Zacks.com

Boston Scientific Remains Neutral - Analyst Blog
3/8/2012 11:59:01 AM - Zacks.com

Reaffirming DexCom at Neutral - Analyst Blog
3/8/2012 11:15:01 AM - Zacks.com

The Rational Case For Dividend Growth Investing (Part 1)
3/8/2012 10:34:24 AM - SeekingAlpha

The Zacks Analyst Blog Highlights: Applied Materials, Covidien, Johnson & Johnson, Becton Dickinson and C.R. Bard - Press Releases
3/8/2012 9:30:01 AM - Zacks.com

FDA Nod for Covidien's Solitaire - Analyst Blog
3/7/2012 1:00:01 PM - Zacks.com

Bifurcate Your Portfolio.....And Thinking
3/6/2012 2:40:45 PM - Ted Allrich

Wright Intros CLAW II System - Analyst Blog
3/6/2012 1:00:01 PM - Zacks.com

Volcano Reaffirmed at Neutral - Analyst Blog
3/5/2012 3:30:01 PM - Zacks.com

Conmed Initiates Dividend - Analyst Blog
3/5/2012 12:45:01 PM - Zacks.com

FDA Delays Eliquis Verdict - Analyst Blog
3/2/2012 7:08:01 PM - Zacks.com

BSX Unveils Promus Element in Japan - Analyst Blog
3/2/2012 6:47:01 PM - Zacks.com

Exactech Underperforms in 4Q - Analyst Blog
3/2/2012 9:30:01 AM - Zacks.com

Revenues Rise at Bayer - Analyst Blog
3/1/2012 5:36:01 PM - Zacks.com

The Zacks Analyst Blog Highlights: Dendreon, Merck, Johnson & Johnson, Medivation and CONSOL Energy - Press Releases
3/1/2012 9:30:01 AM - Zacks.com

Bleak Outlook for Dendreon's Provenge - Analyst Blog
2/29/2012 4:30:01 PM - Zacks.com

Neutral on Symmetry Medical - Analyst Blog
2/28/2012 5:37:01 PM - Zacks.com

Hospira Back to Neutral - Analyst Blog
2/28/2012 5:10:01 PM - Zacks.com

Earnings Beat at Valeant Pharma - Analyst Blog
2/28/2012 11:30:01 AM - Zacks.com

Greatbatch's EPS Meets, Net Tanks - Analyst Blog
2/27/2012 10:30:01 AM - Zacks.com

DexCom's EPS Misses, Sales Beat - Analyst Blog
2/24/2012 12:00:01 PM - Zacks.com